NCT06766734 is a NA clinical trial of Tendon Dry Needling in Supraspinatus Tendinopathy, sponsored by Istanbul Training and Research Hospital.

Who is sponsoring NCT06766734?

NCT06766734 is sponsored by Istanbul Training and Research Hospital.

What drugs are being tested in NCT06766734?

Interventions in NCT06766734: Tendon Dry Needling, Sham Tendon Dry Needling.

What condition does NCT06766734 study?

NCT06766734 studies Supraspinatus Tendinopathy.

Is NCT06766734 still recruiting?

NCT06766734 is currently completed. Last updated 9 January 2025.

Last reviewed 2025-01-09 · How we verify

NCT06766734

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Ultrasound-Guided Tendon Dry Needling on Pain and Function in Rotator Cuff Tendinopathy

Completed NA Last updated 9 January 2025

What this trial tests

NA trial testing Tendon Dry Needling in Supraspinatus Tendinopathy in 48 participants. Completed in 4 November 2024.

Timeline

10 November 2023

Primary endpoint
10 August 2024

4 November 2024

Quick facts

Lead sponsor	Istanbul Training and Research Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	48
Start date	10 November 2023
Primary completion	10 August 2024
Estimated completion	4 November 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Tendon Dry Needling
Sham Tendon Dry Needling

Conditions studied

Supraspinatus Tendinopathy — all drugs for Supraspinatus Tendinopathy →

Sponsor

Istanbul Training and Research Hospital

Who can join

Adults 40 to 65, any sex, with Supraspinatus Tendinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, we aimed to observe the effect of adding dry needling to therapeutic ultrasound treatment on pain and function in patients with supraspinatus tendinopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Training and Research Hospital trials

Trials by the same sponsor.

NCT07499713 — Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata · enrolling by invitation
NCT07335822 — The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica · NA · recruiting
NCT07363187 — Nailfold Capillaroscopy and Endothelial Biomarkers in Healthcare Workers Exposed to Chronic Low-Dose Ionizing Radiation · not yet recruiting
NCT07415291 — CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis · active not recruiting
NCT07150702 — Effects of Close Follow-up on Patients With Low Back Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06766734 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Training and Research Hospital
Last refreshed: 9 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766734.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing